Abstract: The present invention relates to a wearable pressure ulcer detection sensor, and the wearable pressure ulcer detection sensor according to the present invention includes a pressure sensor measuring pressure based on a change in capacitance caused by physical force, a temperature sensor measuring temperature based on a change in electrical conductivity due to electron hopping, and an impedance sensor including two electrodes spaced apart from each other and in contact with skin.

Abstract: A storage system includes: an interconnector; a plurality of storage devices connected to the interconnector and configured to store data; a host device connected to the interconnector, and configured to: set a plurality of erasure coding schemes that are different from each other, and determine a target erasure coding scheme corresponding to original data to be stored in the plurality of storage devices among the plurality of erasure coding schemes, based on device characteristics of the plurality of storage devices or data characteristics of the original data; and an erasure coding controller configured to: divide the original data into a plurality of data blocks corresponding to the target erasure coding scheme, and generate one or more parity blocks corresponding to the target erasure coding scheme, by encoding the plurality of data blocks.

Abstract: A fingerprint extraction apparatus includes a fingerprint generation module configured to generate first and second virtual fingerprint images, perform primary image processing on the first virtual fingerprint image and primary and secondary image processing on the second virtual fingerprint images, and generate virtual overlapped fingerprint images by combining the first and second virtual fingerprint images on which image processing is performed; a machine learning module configured to generate a learning model by performing machine learning using the virtual overlapped fingerprint images as input data; and a fingerprint extraction module configured to extract a fingerprint located vertically on a center of a real image by inputting the real image to a target fingerprint extraction learning model, and the primary image processing comprises image processing on a curve forming a fingerprint, and the secondary image processing comprises image processing on a location of the fingerprint in the image.

Abstract: The present invention provides a skull implant-type automatic fluid drain device comprising: a body having a first port to be connected to a catheter, a second port provided opposite the first port, and a flow passage connecting the first port and the second port; a separation member for separating the flow passage into first and second sub-channels; a first valve fixed to the separation member and provided to allow the movement of a fluid that moves from the first port to the second port in the first sub-channel; and a second valve fixed to the separation member and provided to allow the movement of a fluid that moves from the second port to the first port in the second sub-channel, wherein each of the first valve and the second valve has an inflow end portion that is open and a discharge end portion provided in a closed state such that the same is selectively opened at an allowed opening pressure or higher; each of the first valve and the second valve is configured such that the inner flow sectional area de

Abstract: A fingerprint extraction apparatus includes a fingerprint generation module configured to generate first and second virtual fingerprint images, perform primary image processing on the first virtual fingerprint image and primary and secondary image processing on the second virtual fingerprint images, and generate virtual overlapped fingerprint images by combining the first and second virtual fingerprint images on which image processing is performed; a machine learning module configured to generate a learning model by performing machine learning using the virtual overlapped fingerprint images as input data; and a fingerprint extraction module configured to extract a fingerprint located vertically on a center of a real image by inputting the real image to a target fingerprint extraction learning model, and the primary image processing comprises image processing on a curve forming a fingerprint, and the secondary image processing comprises image processing on a location of the fingerprint in the image.

Abstract: The present disclosure relates to a projection device, and more particularly, to a projection device including: a projector module configured to provide an image to a screen; and a lens module between a user's eyes and the screen, wherein the project module includes: a display module configured to provide a certain image; and a backlight module configured to provide light to the display module such that the image provided by the display module is projected on the screen, wherein the display module is between the backlight module and the screen, the display module is configured to induce a convergence reaction on the user's eyes such that the image projected on the screen has a convergence distance, and the lens module is configured to induce a focus reaction on the user's eyes and change a focal length of the image reproduced by the display module within a certain range.

Abstract: The present invention relates to a pen-type medical fluorescent imaging device comprising: a probe which is elongated in the longitudinal direction and has an image capture unit at one end; a plurality of light source units surrounding the image capture unit; and a control unit for controlling the light source units, wherein the light source units comprise: a first light source for emitting light of a first wavelength range so that a blood vessel is marked by a first fluorescent material; and a second light source for emitting light of a second wavelength range so that a glioma is marked by a second fluorescent material, wherein the first and second light sources are selectively controlled by the control unit.

Abstract: The present disclosure relates to a projection device, and more particularly, to a projection device including: a projector module configured to provide an image to a screen; and a lens module between a user's eyes and the screen, wherein the project module includes: a display module configured to provide a certain image; and a backlight module configured to provide light to the display module such that the image provided by the display module is projected on the screen, wherein the display module is between the backlight module and the screen, the display module is configured to induce a convergence reaction on the user's eyes such that the image projected on the screen has a convergence distance, and the lens module is configured to induce a focus reaction on the user's eyes and change a focal length of the image reproduced by the display module within a certain range.

Abstract: The present invention provides a skull implant-type automatic fluid drain device comprising: a body having a first port to be connected to a catheter, a second port provided opposite the first port, and a flow passage connecting the first port and the second port; a separation member for separating the flow passage into first and second sub-channels; a first valve fixed to the separation member and provided to allow the movement of a fluid that moves from the first port to the second port in the first sub-channel; and a second valve fixed to the separation member and provided to allow the movement of a fluid that moves from the second port to the first port in the second sub-channel, wherein each of the first valve and the second valve has an inflow end portion that is open and a discharge end portion provided in a closed state such that the same is selectively opened at an allowed opening pressure or higher; each of the first valve and the second valve is configured such that the inner flow sectional area de

Abstract: The present disclosure relates to a near-eye display device, and more particularly, to a near-eye display device including: a display module configured to reproduce a predetermined image; a lens module positioned in front of the display module for being located between the user's eyes and the display module; and a backlight module positioned behind the display module and providing light to the display module, wherein: the display module induces a convergence response of the user's eyes such that the image may have a predetermined convergence distance; the lens module induces a focusing response of the user's eyes such that a focal distance to the image reproduced by the display module may be varied within a predetermined range; and when the image reproduced by the display module has a specific focal distance by operation of the lens module, the backlight module operates to provide light to the display module such that the image reproduced by the display module may be incident in the user's eyes while having t

Abstract: Provided are a rapid antimicrobial susceptibility test, based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and an automated cell image analysis system therefor. The antimicrobial susceptibility test is rapidly performed based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and this makes it possible to obtain highly reliable test results faster by six to seven times than the standard method recommended by Clinical and Laboratory Standards Institute (CLSI).

Abstract: Provided is a method for isolating and proliferating autologous cancer antigen-specific CD8+T cells, and more particularly, a method for selecting an epitope recognized by CD8+ T cells from autologous cancer antigens present in blood of individual cancer patients; and isolating autologous cancer antigen-specific CD8+ T cells by using a peptide of the selected epitope, and a method of massively proliferating CD8+ T cells by using the method. According to the present invention, it is possible to isolate autologous cancer antigen-specific CD8+ T cells by using the peptide of the CD8 T cell epitope of the autologous cancer antigen present in blood of individual cancer patients instead of a heterologous antigen. Therefore, by using T cells recognizing the autologous cancer antigen, it is possible to effectively select and eliminate cancer cells derived from the cancer patient's own cells. Thus, T cells can be applied to treatment and alleviation of cancer diseases without side effects.

Abstract: Provided is a method for isolating and proliferating autologous cancer antigen-specific CD8+ T cells, and more particularly, a method for selecting an epitope recognized by CD8+ T cells from autologous cancer antigens present in blood of individual cancer patients; and isolating autologous cancer antigen-specific CD8+ T cells by using a peptide of the selected epitope, and a method of massively proliferating CD8+ T cells by using the method. According to the present invention, it is possible to isolate autologous cancer antigen-specific CD8+ T cells by using the peptide of the CD8 T cell epitope of the autologous cancer antigen present in blood of individual cancer patients instead of a heterologous antigen. Therefore, by using T cells recognizing the autologous cancer antigen, it is possible to effectively select and eliminate cancer cells derived from the cancer patient's own cells. Thus, T cells can be applied to treatment and alleviation of cancer diseases without side effects.

Abstract: The present invention relates to a novel bioactivity testing structure for single cell tracking using a gelling agent and a bioactivity testing system including the testing structure. The present invention also relates to bioactivity testing, drug susceptibility testing, antibiotic screening, and diagnostic methods using the testing structure. The bioactivity testing structure of the present invention enables very rapid and simple drug susceptibility testing of bacteria, particularly Mycobacterium tuberculosis, drug screening, and bacterial diagnosis. Particularly, the use of the testing structure enables DST and diagnosis of bacteria only by pretreatment without the need to concentrate human sputum samples irrespective of inoculum effect, ensuring rapid, accurate, and simple testing compared to conventional tuberculosis diagnosis or DST systems. In addition, the testing structure of the present invention simultaneously enables the diagnosis and drug susceptibility testing of tuberculosis.

Abstract: Provided are a rapid antimicrobial susceptibility test, based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and an automated cell image analysis system therefor. The antimicrobial susceptibility test is rapidly performed based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and this makes it possible to obtain highly reliable test results faster by six to seven times than the standard method recommended by Clinical and Laboratory Standards Institute (CLSI).

Abstract: Provided are a rapid antimicrobial susceptibility test, based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and an automated cell image analysis system therefor. The antimicrobial susceptibility test is rapidly performed based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and this makes it possible to obtain highly reliable test results faster by six to seven times than the standard method recommended by Clinical and Laboratory Standards Institute (CLSI).

Abstract: A skull implant medication injection port comprises: a mounted portion placed on an upper section of a port insertion hole in a patient's cranium and a medication inlet on a top surface; a medication injection diaphragm that seals the medication inlet of the mounted portion where a needle for injecting a medication is inserted; a medication storage portion coupled with a bottom of the mounted portion stores the medication injected through the medication injection diaphragm; a medication discharge pipe connected to the medication storage portion discharges the medication stored in the medication storage portion; and a rib formed on a perimeter between the mounted portion and the medication storage portion that has a diameter larger than an inner diameter of the port insertion hole. A height of the mounted portion is generally about 4 to 7 mm, and a height of the medication storage portion is generally about 2 to 4.2 mm.

Abstract: Provided is a method for isolating and proliferating autologous cancer antigen-specific CD8+ T cells, and more particularly, a method for selecting an epitope recognized by CD8+ T cells from autologous cancer antigens present in blood of individual cancer patients; and isolating autologous cancer antigen-specific CD8+ T cells by using a peptide of the selected epitope, and a method of massively proliferating CD8+ T cells by using the method. According to the present invention, it is possible to isolate autologous cancer antigen-specific CD8+ T cells by using the peptide of the CD8 T cell epitope of the autologous cancer antigen present in blood of individual cancer patients instead of a heterologous antigen. Therefore, by using T cells recognizing the autologous cancer antigen, it is possible to effectively select and eliminate cancer cells derived from the cancer patient's own cells. Thus, T cells can be applied to treatment and alleviation of cancer diseases without side effects.

Abstract: The present invention relates to a pen-type medical fluorescent imaging device comprising: a probe which is elongated in the longitudinal direction and has an image capture unit at one end; a plurality of light source units surrounding the image capture unit; and a control unit for controlling the light source units, wherein the light source units comprise: a first light source for emitting light of a first wavelength range so that a blood vessel is marked by a first fluorescent material; and a second light source for emitting light of a second wavelength range so that a glioma is marked by a second fluorescent material, wherein the first and second light sources are selectively controlled by the control unit.

Abstract: A wearable device comprises a body portion, a strap portion coupled with the body portion, the strap portion provided to allow the body portion to be worn on a human body, and a connection module provided in a portion of the strap portion and a portion of the body to couple the strap portion with the body portion. The connection module comprises a connection pin portion provided in the strap portion to detachably couple the strap portion with the body portion and a holder portion provided in an end of the strap portion, the connection pin portion inserted in the holder portion.